Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,751–5,775 of 7,816 matching trials · page 231 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Effect of Rapid Transcranial Magnetic Stimulation (rTMS) on Aggression in Forensic Patients NCT02990442 rTMS Runs in: Canada · 1 site |
NA other |
UNKNOWN | 10 | St. Joseph's Healthcare Hamilton OTHER |
2019-04-22 |
|
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care NCT00400062 Runs in: United States · 3 sites |
NA other |
COMPLETED | 800 | VA Office of Research and Development OTHER_GOV |
2019-04-19 |
|
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE) NCT02258152 SYN120; Placebo Runs in: United States · 20 sites |
PHASE2 other |
COMPLETED | 82 | Biotie Therapies Inc. INDUSTRY |
2019-04-19 |
|
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease NCT02331784 Computerized Plasticity-based Software; Commercially available Video Game Runs in: United States · 1 site |
NA other |
COMPLETED | 68 | Posit Science Corporation INDUSTRY |
2019-04-19 |
|
Communication Skills vs. Mindfulness for IPV NCT03672942 Communication Skills Training; Mindfulness; Placebo |
NA other |
UNKNOWN | 50 | University of Houston OTHER |
2019-04-18 |
|
Effect of Digital Cognitive Training on the Functionality of Older Adults With Mild Cognitive Impairment (MCI) NCT03911765 digital cognitive training Runs in: Brazil · 1 site |
PHASE1 other |
UNKNOWN | 40 | Universidade Federal do Rio de Janeiro OTHER |
2019-04-17 |
|
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging NCT02931136 Huperzine A; Placebo Runs in: China · 1 site |
PHASE4 other |
UNKNOWN | 300 | Shanghai Mental Health Center OTHER |
2019-04-16 |
|
Connecting Through Caregiving: Reappraising Intergeneration Relationships NCT03030027 Connecting Through Caregiving; Basic Skills Building Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 80 | The Hong Kong Polytechnic University OTHER |
2019-04-16 |
|
Advanced Dementia and End-of-life NCT03548142 provision of relevant information Runs in: Germany · 1 site |
NA other |
COMPLETED | 38 | Technical University of Munich OTHER |
2019-04-16 |
|
Transcranial Magnetic Stimulation and Cognitive Stimulation in Mild Cognitive Impairment NCT03906903 Repetitive Transcranial Magnetic Stimulation; Cognitive Stimulation Runs in: Mexico · 1 site |
NA other |
UNKNOWN | 20 | Universidad Autonoma de Queretaro OTHER |
2019-04-16 |
|
Multi-center Imaging Genetics Studies in China NCT02681822 Runs in: China · 1 site |
NA other |
UNKNOWN | 10,000 | Tianjin Medical University General Hospital OTHER |
2019-04-10 |
|
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism NCT00198107 Aripiprazole; Placebo; D-cycloserine Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 81 | Indiana University OTHER |
2019-04-09 |
|
The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia NCT03906123 NBP; Placebos Runs in: China · 1 site |
NA other |
UNKNOWN | 64 | Tianjin Medical University General Hospital OTHER |
2019-04-08 |
|
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study NCT01056965 davunetide (AL-108, NAP); Placebo nasal spray Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | University of California, San Francisco OTHER |
2019-04-05 |
|
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis NCT02632786 NEOD001; Placebo Runs in: Australia; Austria; France; Germany; Greece; Israel; Ital... · 40 sites |
PHASE2 other |
COMPLETED | 129 | Prothena Biosciences Ltd. INDUSTRY |
2019-04-05 |
|
Ketamine Versus Midazolam for Prehospital Agitation NCT03554915 Ketamine-based protocol; Midazolam-based protocol Runs in: United States · 1 site |
NA other |
COMPLETED | 314 | Hennepin Healthcare Research Institute OTHER |
2019-04-05 |
|
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects NCT00612872 [123I]CLINDE Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 46 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition NCT00657813 MNI-330 as a brain SPECT tracer of Beta-Amyloid Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 3 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects NCT00870519 I-123-MNI-168; 123-I MNI-168 Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 2 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease NCT00886951 I123MNI388/I123MNI390 Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 2 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition NCT00968097 123-I MNI-340 Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 12 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions NCT01028209 [18F] PBR06 Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 12 | Institute for Neurodegenerative Disorders OTHER |
2019-04-03 |
|
Detecting Dementia Earlier NCT03900936 Neuropsychological tests Runs in: United Kingdom · 1 site |
NA other |
UNKNOWN | 20 | South Tees Hospitals NHS Foundation Trust OTHER |
2019-04-03 |
|
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study NCT01834716 Aerobic vs. Non-Aerobic exercise Runs in: United States · 1 site |
NA other |
COMPLETED | 16 | Mayo Clinic OTHER |
2019-03-29 |
|
A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly NCT02172612 Arm 1 Education Session Runs in: United States · 1 site |
NA other |
COMPLETED | 50 | Daniela Moga OTHER |
2019-03-29 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial